Strategies to advance the field of neuroimmunology by embracing its complexity via inclusion of its multidisciplinary properties were discussed at a meeting in Cold Spring Harbor. Attendees proposed fostering of open communications and funding of collaborations across disciplines, and the recognition that our understanding of the neuroimmune system requires interdisciplinary science.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout

References
Krakauer, J. W., Ghazanfar, A. A., Gomez-Marin, A., MacIver, M. A. & Poeppel, D. Neuron 93, 480–490 (2017).
Huh, G. S. et al. Science 290, 2155–2159 (2000).
Erny, D. et al. Nat. Neurosci. 18, 965–977 (2015).
Bordt, E. A., Ceasrine, A. M. & Bilbo, S. D. Glia 68, 1085–1099 (2020).
Osborne, N. R. & Davis, K. D. Int. Rev. Neurobiol. 164, 277–307 (2022).
Blennow, K. et al. Nat. Rev. Dis. Primers 2, 16084 (2016).
Yang, A. C. et al. Nature 583, 425–430 (2020).
Heng, T. S. P., Painter, M. W. & The Immunological Genome Project Consortium. Nat. Immunol. 9, 1091–1094 (2008).
Nakandakari-Higa, S. et al. Nature 627, 399–406 (2024).
Clark, I. C. et al. Science 372, eabf1230 (2021).
Mora, F., Segovia, G., Del Arco, A., de Blas, M. & Garrido, P. Brain Res. 1476, 71–85 (2012).
Kertser, A. et al. Sci. Adv. 5, eaav4111 (2019).
Levite, M. Front. Immunol. 12, 617658 (2021).
Cornelison, C. & Fadel, S. Int. J. Mol. Sci. 23, 8496 (2022).
Holloway, P. M. et al. J. Neurosci. Res. 99, 1276–1307 (2021).
Acknowledgements
The Systems Neuroimmunology conference was generously funded by Andrea B. and Peter D. Klein. We are grateful to the Banbury Center of the Cold Spring Harbor Laboratories for hosting us. We would like to acknowledge the following funding sources: NIH 1R01AI182126 (C.B.); The New Jersey Alliance for Clinical and Translational Science and New Jersey Commission on Brain Injury Research (L.M.B.); NIH R21DK130015, R35GM147094, the University of Texas System STARS program, and the Rita Allen Foundation Grant (M.D.B.); NIH R01 NS120895 and R21 NS130282 (B.P.D.); G5 (Institut Pasteur), ERC Starting grant (BrainGate), Agence Nationale de la Recherche (ANR-PRC), Ville de Paris EMERGENCE(S), Alzheimer’s Association (AARG-22-917964), and Fédération pour la Recherche sur le Cerveau (A.D.); NIH 1R01AI140326 and 1R01AI170844 (M.F.F.); NIH R01AT009365 and R21MH108154 (M.G.G.); NIH UH3NS127251, R01NS126252, RF1NS113840, and DoD W81XWH-19-1-0160 (P.M.G); NIH R35GM149284, R01GM101056, and R21AI169842 (J.E.I.); Altos Labs (S.R.); NSF IOS 1755348 (I.S.); NIH R01MH118329, R01NS106721, RF1AG068558, R01AG072489, ERC-951515 (A.S.); NIH R01AI151163, the Food Allergy Science Initiative, and the Massachusetts General Hospital Howard M. Goodman Fellowship (C.L.S.); NIH U01DA058527 and R01DA052859 (D.W.W.).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
C.L.S. is a paid consultant for Bayer and Merck and receives sponsored research support from GSK. The remaining authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Iyer, H., Benoist, C., Bilbo, S.D. et al. Systems neuroimmunology: current bottlenecks, research priorities and future directions. Nat Immunol 26, 325–329 (2025). https://doi.org/10.1038/s41590-025-02092-z
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41590-025-02092-z